QCG
MEDP icon

Quadrant Capital Group’s Medpace MEDP Stock Holding History

Quadrant Capital Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
2,829
-4
-0.1% -$1.85K 0.04% 421
2026
Q1 		$1.36M Sell
2,833
-160
-5% -$81.9K 0.04% 433
2025
Q4 		$1.68M Buy
2,993
+417
+16% +$237K 0.05% 316
2025
Q3 		$1.32M Buy
2,576
+189
+8% +$82.5K 0.04% 381
2025
Q2 		$749K Sell
2,387
-972
-29% -$292K 0.03% 627
2025
Q1 		$1.02M Buy
3,359
+1,072
+47% +$361K 0.04% 376
2024
Q4 		$760K Buy
2,287
+93
+4% +$31.5K 0.05% 241
2024
Q3 		$732K Sell
2,194
-6
-0.3% -$2.28K 0.05% 262
2024
Q2 		$906K Buy
2,200
+1,739
+377% +$689K 0.07% 206
2024
Q1 		$186K Hold
461
– – 0.01% 666
2023
Q4 		$141K Sell
461
-4,135
-90% -$1.12M 0.01% 799
2023
Q3 		$1.11M Buy
4,596
+189
+4% +$48.3K 0.11% 134
2023
Q2 		$1.06M Buy
4,407
+2
+0% +$415 0.11% 134
2023
Q1 		$828K Buy
4,405
+3,934
+835% +$814K 0.09% 169
2022
Q4 		$100K Buy
471
+88
+23% +$17.6K 0.01% 772
2022
Q3 		$60K Buy
383
+14
+4% +$2.23K 0.01% 940
2022
Q2 		$55K Buy
369
+69
+23% +$9.99K 0.01% 841
2022
Q1 		$49K Buy
300
+21
+8% +$3.46K 0.01% 930
2021
Q4 		$61K Buy
279
+47
+20% +$9.84K 0.01% 843
2021
Q3 		$44K Buy
232
+219
+1,685% +$39.9K 0.01% 919
2021
Q2 		$2K Hold
13
– – ﹤0.01% 2118
2021
Q1 		$2K Buy
13
+9
+225% +$1.38K ﹤0.01% 2088
2020
Q4 		$1K Buy
+4
New +$504 ﹤0.01% 2147
2020
Q2 		– Sell
-436
Closed -$32K – 2328
2020
Q1 		$32K Hold
436
– – 0.01% 1083
2019
Q4 		$36K Hold
436
– – ﹤0.01% 1485
2019
Q3 		$36K Hold
436
– – 0.01% 1360
2019
Q2 		$28K Buy
+436
New +$25.1K ﹤0.01% 1492

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Quadrant Capital Group's MEDP Position: Q2 2026 in Review

Quadrant Capital Group reduced its Medpace (MEDP) stake by 0.14% in Q2 2026, selling an estimated $1.85K and leaving 2,829 shares worth $1.5M. The position accounts for 0.04% of the portfolio, ranked #421.

Quadrant Capital Group first reported a position in MEDP in Q2 2019 and has held it in 27 quarters since. The position peaked at $1.68M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Quadrant Capital Group held 2,829 shares of Medpace worth $1.5M as of Q2 2026.
  • Quadrant Capital Group sold 4 Medpace shares in Q2 2026, an estimated $1.85K.
  • Medpace made up 0.04% of Quadrant Capital Group's portfolio in Q2 2026, its #421 holding.
  • Quadrant Capital Group first reported a position in Medpace in Q2 2019 and has held it in 27 quarters since.
  • Quadrant Capital Group's Medpace position peaked at $1.68M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.